IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 148 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,665,000 | +3169.8% | 651,000 | +2645.3% | 0.02% | +2100.0% |
| Q1 2021 | $265,000 | -24.3% | 23,713 | -22.5% | 0.00% | 0.0% |
| Q4 2020 | $350,000 | -74.5% | 30,604 | -77.0% | 0.00% | -80.0% |
| Q2 2020 | $1,370,000 | +204.4% | 133,000 | +197.6% | 0.01% | +150.0% |
| Q1 2020 | $450,000 | -34.6% | 44,684 | -32.9% | 0.00% | -33.3% |
| Q4 2018 | $688,000 | -26.1% | 66,622 | +30.6% | 0.00% | 0.0% |
| Q3 2018 | $931,000 | -61.9% | 51,008 | -60.1% | 0.00% | -62.5% |
| Q2 2018 | $2,443,000 | +126.4% | 127,765 | +88.2% | 0.01% | +166.7% |
| Q3 2016 | $1,079,000 | +538.5% | 67,900 | +299.4% | 0.00% | +200.0% |
| Q2 2013 | $169,000 | -60.9% | 17,000 | -56.4% | 0.00% | -80.0% |
| Q4 2012 | $432,000 | – | 38,971 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |